At 12.30 next Thursday, creditors of Pharmapod will log on to a Zoom conference call to liquidate the business formally. The liquidation is not a surprise, and it is unlikely to be controversial. After all, the company’s assets and intellectual property have already been commandeered, and quickly sold, by its largest creditor. But it will also mark the formal end of a business that raised millions of euro in funding and generated a string of high-profile international deals. Founded by pharmacist-cum-entrepreneur Leonora O’Brien in 2012, Pharmapod developed a cloud-based platform to reduce medication errors for patients. The company was attempting…

Want to continue reading?

Join today with an Annual membership and get full access to The Currency for just €200 (68c per day) or try monthly membership for just €5 for your first month.

Subscribe

Cancel at any time.

Are you already a member? .